Martina L. Lei
Hong Kong, HCW, Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Adipocyte-derived FABP4 promotes metabolism-associated steatotic liver-induced hepatocellular carcinoma by driving ITGB1-mediated β-catenin activation.
Journal: The Journal of clinical investigation
Published: April 29, 2025
Deciphering adenosine signaling in hepatocellular carcinoma: Pathways, prognostic models, and therapeutic implications.
Journal: Clinical and molecular hepatology
Published: November 26, 2024
Inhibiting Yes-associated protein alleviates CCl4 liver fibrosis in mice by reducing epithelial mesenchymal transition
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: November 10, 2024
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma.
Journal: Nature communications
Published: October 26, 2024
Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: September 27, 2024
Reply to correspondence on "UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma".
Journal: Clinical and molecular hepatology
Published: August 01, 2024
UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma: Editorial on "UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL".
Journal: Clinical and molecular hepatology
Published: July 15, 2024
Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma.
Journal: Nature communications
Published: October 31, 2022
SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression.
Journal: JHEP reports : innovation in hepatology
Published: April 12, 2022
Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma.
Journal: Cancer research
Published: August 31, 2021
Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers.
Journal: Frontiers in cell and developmental biology
Published: April 09, 2021
Mouse Spexin: (III) Differential Regulation by Glucose and Insulin in Glandular Stomach and Functional Implication in Feeding Control.
Journal: Frontiers in endocrinology
Published: March 17, 2021
Last Updated: 09/26/2026